Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nephrotic syndrome and malignancy].

Hiroshi Matsumoto1, Yume Nagaoka

  • 1Department of Nephrology, Tokyo Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiological and Clinical Implications of Timing of Hemoglobin Measurement in Hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Catalytic Promiscuity Underpins Metabolic Resistance to Auxinic Herbicides in <i>Echinochloa phyllopogon</i>.

Journal of agricultural and food chemistry·2026
Same author

Loxoprofen overdose without toxicity: pharmacokinetics of loxoprofen and metabolites analysed by liquid chromatography-mass spectrometry: a case report.

International journal of emergency medicine·2026
Same author

Safety and Efficacy of Oral Tacrolimus Induction Therapy in Elderly Patients with Ulcerative Colitis: A Subanalysis of a Large Multicenter Retrospective Cohort Study.

Gerontology·2026
Same author

Elevated hemoglobin levels associated with severe sleep-disordered breathing in hemodialysis patients not receiving erythropoiesis-stimulating agents: a case series.

CEN case reports·2026
Same author

Subcutaneous adipose tissue loss as an early indicator of cancer cachexia in unresectable pancreatic cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Nephrotic syndrome can be linked to cancer, though this association is rare. While proteinuria remission after cancer treatment and relapse with cancer recurrence are observed, the underlying cause remains unclear.

Area of Science:

  • Nephrology
  • Oncology
  • Pathology

Context:

  • Nephrotic syndrome is infrequently diagnosed in patients with cancer.
  • However, a significant association exists between nephrotic syndrome and both solid tumors and hematologic malignancies.
  • This association occurs at a rate suggesting it is not coincidental.

Purpose:

  • To explore the clinical criteria and theoretical pathophysiology linking malignancy and nephrotic syndrome.
  • To highlight the established clinical criteria and the missing pathophysiological link.

Summary:

  • Malignancy-associated glomerulopathy is theoretically defined by two clinical criteria: remission of proteinuria after tumor removal/treatment and relapse of proteinuria upon malignancy recurrence.
  • Despite these clinical observations, the underlying pathophysiological mechanism connecting malignancy and nephrotic syndrome has not been established.

Related Experiment Videos

  • This highlights a critical gap in understanding the relationship between these two conditions.

    • Impact:

    • This research underscores the need for further investigation into the pathophysiological mechanisms driving malignancy-associated glomerulopathy.
    • Understanding this link could lead to improved diagnostic and therapeutic strategies for patients presenting with both conditions.
    • It emphasizes the importance of considering malignancy in patients with nephrotic syndrome and vice versa.